Molecular abnormalities in chronic myeloid leukemia



Title Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis
Author(s) A. Di Bacco, K. Keeshan, Shawn L. McKenna, T. G. Cotter
Journal The Oncologist
Date 2000
Volume 5
Issue 5
Start page 405
End page 415
Abstract Chronic myeloid leukemia (CML) is a disease of the hematopoietic system, characterized by the presence of the Bcr-Abl oncoprotein. The main characteristics of this disease include adhesion independence, growth factor independence, and resistance to apoptosis. Loss or mutation of the tumor suppressor gene, p53, is one of the most frequent secondary mutations in CML blast crisis. The transition between chronic phase and blast crisis is associated with increased resistance to apoptosis correlating with poor prognosis. This review focuses on the involvement of these two oncoproteins in the development and progression of the apoptotic-resistant phenotype in CML.

Using APA 6th Edition citation style.

[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]

Times viewed: 446

Adding this citation to "My List" will allow you to export this citation in other styles.